A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
Manuel A de la TorreJuan Buades-MateuPedro A de la RosaAlberto LueFrancisco J BustamanteMaría T SerranoMilagros TestillanoSara LorenteJuan I ArenasCristina GilMercedes IñarrairaeguiBruno SangroPublished in: Liver international : official journal of the International Association for the Study of the Liver (2016)
In a cohort of patients with HCC and PVI treatment with RE was associated with a more prolonged survival compared with SOR.